Clin Mol Hepatol February 2023 PMID 36517002

Global incidence and prevalence of nonalcoholic fatty liver disease.

Margaret Lp Teng, Cheng Han Ng, Daniel Q Huang, Kai En Chan, Darren Jh Tan, Wen Hui Lim, Ju Dong Yang, Eunice Tan, Mark D Muthiah

Full text PDF Download social card

Mentions

Peak: 2 in Mar 2023

across 3 sources since Mar 2023

Extended reach

23,116

potential audience

Total likes

Video views

435

Mentions per month

Mar 2023 – Jun 2024

Where it's discussed

News9 articles
X / Twitter3 posts
YouTube3 videos

AI synopsis

What people are saying

The comments reflect a general agreement on the importance of the study, with mentions of regional disparities and increasing trends highlighting specific data, such as NAFLD rates exceeding 40% in some areas. The tone balances recognition of the study's significance with curiosity, suggesting a moderate level of engagement that underscores the article's relevance without portraying it as groundbreaking or dismissive.

AgreementModerate agreement

Most discussions acknowledge the significance of the research, emphasizing the global health implications of NAFLD prevalence.

InterestModerate interest

Posts show moderate enthusiasm, expressing curiosity about regional differences and future trends without overwhelming excitement.

EngagementModerate engagement

Commenters reference specific data points such as rising prevalence rates and regional disparities, indicating active engagement.

ImpactModerate impact

The discussions convey that this publication has some influence on raising awareness about NAFLD's global impact and future implications.

Abstract in brief

Nonalcoholic fatty liver disease (NAFLD) is a major cause of liver disease globally, affecting about 32% of adults, with higher rates in males (40%) compared to females (26%).
Its prevalence has risen over time, increasing from 26% in studies before 2005 to 38% in more recent studies (2016 and beyond).
Regional differences are significant, with rates exceeding 40% in the Americas and South-East Asia, and projected increases in NAFLD prevalence are expected by 2030 if current trends continue.

Read the full abstract